Author:
Kolesnikov-Gauthier Hélène,Vanlemmens Laurence,Baranzelli Marie-Christine,Vennin Philippe,Servent Véronique,Fournier Charles,Carpentier Philippe,Bonneterre Jacques
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F (2002) Prognostic significance of complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 86:1041–1046
2. Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N (2008) Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol 26:778–785
3. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project protocols B-18. J Clin Oncol 15:2483–2493
4. Bear HD, Anderson S, Smith RE, Geyer CE Jr, Mamounas EP, Fisher B, Brown AM, Robidoux A, Margolese R, Kahlenberg MS, Paik S, Soran A, Wickerham DL, Wolmark N (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer. National surgical adjuvant breast and bowel project protocols B27. J Clin Oncol 24:2019–2027
5. Heys SD, Hutcheon AW, Sarkar TK, Ogston KN, Miller ID, Payne S, Smith I, Walker LG, Eremin O, Aberdeen Breast Group (2003) Neoadjuvant docetaxel in breast cancer. 3 years survival results from the Aberdeen trial. Clin Breast Cancer 3(Suppl 2):S69–S74
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献